12-1856077-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_172364.5(CACNA2D4):​c.2087A>G​(p.His696Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00297 in 1,613,972 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (β˜…β˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H696Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.014 ( 69 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 42 hom. )

Consequence

CACNA2D4
NM_172364.5 missense

Scores

1
6
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 8.02

Publications

7 publications found
Variant links:
Genes affected
CACNA2D4 (HGNC:20202): (calcium voltage-gated channel auxiliary subunit alpha2delta 4) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
CACNA2D4 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal cone dystrophy 4
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007865012).
BP6
Variant 12-1856077-T-C is Benign according to our data. Variant chr12-1856077-T-C is described in ClinVar as Benign. ClinVar VariationId is 262813.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0144 (2195/152304) while in subpopulation AFR AF = 0.0478 (1988/41556). AF 95% confidence interval is 0.0461. There are 69 homozygotes in GnomAd4. There are 1054 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 69 AR,Unknown,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D4NM_172364.5 linkc.2087A>G p.His696Arg missense_variant Exon 22 of 38 ENST00000382722.10 NP_758952.4 Q7Z3S7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D4ENST00000382722.10 linkc.2087A>G p.His696Arg missense_variant Exon 22 of 38 1 NM_172364.5 ENSP00000372169.4 Q7Z3S7-1
CACNA2D4ENST00000586184.5 linkc.2087A>G p.His696Arg missense_variant Exon 22 of 37 5 ENSP00000465060.1 Q7Z3S7-5
CACNA2D4ENST00000587995.5 linkc.2012A>G p.His671Arg missense_variant Exon 21 of 37 5 ENSP00000465372.1 K7EJY1
CACNA2D4ENST00000585708.5 linkc.1895A>G p.His632Arg missense_variant Exon 22 of 37 5 ENSP00000467697.1 Q7Z3S7-6
CACNA2D4ENST00000588077.5 linkc.1895A>G p.His632Arg missense_variant Exon 22 of 38 5 ENSP00000468530.1 Q7Z3S7-4
CACNA2D4ENST00000444595.6 linkn.*333A>G non_coding_transcript_exon_variant Exon 22 of 37 1 ENSP00000403371.2 E7EUE0
CACNA2D4ENST00000444595.6 linkn.*333A>G 3_prime_UTR_variant Exon 22 of 37 1 ENSP00000403371.2 E7EUE0

Frequencies

GnomAD3 genomes
AF:
0.0144
AC:
2191
AN:
152186
Hom.:
69
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0479
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00910
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000588
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.00379
AC:
945
AN:
249266
AF XY:
0.00298
show subpopulations
Gnomad AFR exome
AF:
0.0453
Gnomad AMR exome
AF:
0.00440
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000655
Gnomad OTH exome
AF:
0.00248
GnomAD4 exome
AF:
0.00177
AC:
2592
AN:
1461668
Hom.:
42
Cov.:
32
AF XY:
0.00162
AC XY:
1180
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.0453
AC:
1517
AN:
33468
American (AMR)
AF:
0.00445
AC:
199
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86256
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53402
Middle Eastern (MID)
AF:
0.00659
AC:
38
AN:
5768
European-Non Finnish (NFE)
AF:
0.000495
AC:
550
AN:
1111850
Other (OTH)
AF:
0.00460
AC:
278
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
146
292
437
583
729
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0144
AC:
2195
AN:
152304
Hom.:
69
Cov.:
33
AF XY:
0.0142
AC XY:
1054
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.0478
AC:
1988
AN:
41556
American (AMR)
AF:
0.00908
AC:
139
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000588
AC:
40
AN:
68032
Other (OTH)
AF:
0.0109
AC:
23
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
104
208
313
417
521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00487
Hom.:
51
Bravo
AF:
0.0158
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0380
AC:
153
ESP6500EA
AF:
0.000120
AC:
1
ExAC
AF:
0.00436
AC:
527
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.000872
EpiControl
AF:
0.000830

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal cone dystrophy 4 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.46
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.17
T;.;.;.;.;.
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Uncertain
0.96
D
MetaRNN
Benign
0.0079
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.7
M;.;.;M;.;.
PhyloP100
8.0
PrimateAI
Uncertain
0.49
T
PROVEAN
Pathogenic
-5.1
D;.;.;.;.;.
REVEL
Benign
0.28
Sift
Benign
0.20
T;.;.;.;.;.
Sift4G
Benign
0.11
T;T;T;T;T;D
Polyphen
1.0
D;.;.;.;.;.
Vest4
0.86
MVP
0.42
MPC
0.61
ClinPred
0.025
T
GERP RS
4.2
Varity_R
0.56
gMVP
0.72
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115228472; hg19: chr12-1965243; COSMIC: COSV99028009; COSMIC: COSV99028009; API